Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Chubb
Cipla
Teva
Fuji

Generated: September 17, 2019

DrugPatentWatch Database Preview

Drug Price Trends for NARATRIPTAN HCL

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Drug Price Trends for NARATRIPTAN HCL

Average Pharmacy Cost for NARATRIPTAN HCL

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Glossary
Drug Name NDC Price/Unit ($) Unit Date
NARATRIPTAN HCL 2.5 MG TABLET 00054-0279-03 2.34841 EACH 2019-08-21
NARATRIPTAN HCL 2.5 MG TABLET 23155-0055-19 2.34841 EACH 2019-08-21
NARATRIPTAN HCL 2.5 MG TABLET 62756-0437-69 2.34841 EACH 2019-08-21
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Subscribe to access the full database, or try a Free Trial

Best Wholesale Price for NARATRIPTAN HCL

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
AMERGE 1MG TABLETS GlaxoSmithKline 00173-0561-00 9 364.74 40.52667 EACH 2019-01-01 - 2020-01-31 Big4
AMERGE 1MG TABLETS GlaxoSmithKline 00173-0561-00 9 405.32 45.03556 EACH 2019-01-01 - 2020-01-31 FSS
AMERGE 2.5MG TABLETS GlaxoSmithKline 00173-0562-00 9 377.03 41.89222 EACH 2019-01-01 - 2020-01-31 Big4
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type

Subscribe to access the full database, or try a Free Trial

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Fish and Richardson
Baxter
Federal Trade Commission
QuintilesIMS
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
Major Patent Expirations 2019 - 2020
 NCE-1 Generic Application Dates 2019 - 2020
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.

Links

Follow DrugPatentWatch:

DrugPatentWatch reviews